 RANCHO CORDOVA, Calif., Sept. 14, 2021 PRNewswire -- ThermoGenesis Holdings, Inc. Nasdaq: THMO, a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company was awarded a 250,000 Phase I Small Business Innovation Research SBIR grant to develop and test the single-use sterile cell processing disposable, that will be used by the fully automated Quintessence System. 